Literature DB >> 33671368

Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics.

Edgardo Becerra1,2, Giovanny Aguilera-Durán1,3, Laura Berumen2, Antonio Romo-Mancillas3, Guadalupe García-Alcocer2.   

Abstract

Multidrug resistance protein-4 (MRP4) belongs to the ABC transporter superfamily and promotes the transport of xenobiotics including drugs. A non-synonymous single nucleotide polymorphisms (nsSNPs) in the ABCC4 gene can promote changes in the structure and function of MRP4. In this work, the interaction of certain endogen substrates, drug substrates, and inhibitors with wild type-MRP4 (WT-MRP4) and its variants G187W and Y556C were studied to determine differences in the intermolecular interactions and affinity related to SNPs using protein threading modeling, molecular docking, all-atom, coarse grained, and umbrella sampling molecular dynamics simulations (AA-MDS and CG-MDS, respectively). The results showed that the three MRP4 structures had significantly different conformations at given sites, leading to differences in the docking scores (DS) and binding sites of three different groups of molecules. Folic acid (FA) had the highest variation in DS on G187W concerning WT-MRP4. WT-MRP4, G187W, Y556C, and FA had different conformations through 25 ns AA-MD. Umbrella sampling simulations indicated that the Y556C-FA complex was the most stable one with or without ATP. In Y556C, the cyclic adenosine monophosphate (cAMP) and ceefourin-1 binding sites are located out of the entrance of the inner cavity, which suggests that both cAMP and ceefourin-1 may not be transported. The binding site for cAMP and ceefourin-1 is quite similar and the affinity (binding energy) of ceefourin-1 to WT-MRP4, G187W, and Y556C is greater than the affinity of cAMP, which may suggest that ceefourin-1 works as a competitive inhibitor. In conclusion, the nsSNPs G187W and Y556C lead to changes in protein conformation, which modifies the ligand binding site, DS, and binding energy.

Entities:  

Keywords:  MRP4; SNPs; binding site; molecular docking; molecular dynamics; protein threading modeling; variants

Mesh:

Substances:

Year:  2021        PMID: 33671368      PMCID: PMC7922701          DOI: 10.3390/molecules26041051

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  42 in total

Review 1.  Advances in homology protein structure modeling.

Authors:  Zhexin Xiang
Journal:  Curr Protein Pept Sci       Date:  2006-06       Impact factor: 3.272

Review 2.  The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein-protein interactions.

Authors:  Christopher M Yates; Michael J E Sternberg
Journal:  J Mol Biol       Date:  2013-07-15       Impact factor: 5.469

3.  Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity.

Authors:  Hanneke G M Wittgen; Jeroen J M W van den Heuvel; Elmar Krieger; Gijs Schaftenaar; Frans G M Russel; Jan B Koenderink
Journal:  Biochem Pharmacol       Date:  2012-04-21       Impact factor: 5.858

4.  CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field.

Authors:  Yifei Qi; Helgi I Ingólfsson; Xi Cheng; Jumin Lee; Siewert J Marrink; Wonpil Im
Journal:  J Chem Theory Comput       Date:  2015-08-27       Impact factor: 6.006

5.  Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.

Authors:  Mayukh Banerjee; Vanessa Marensi; Gwenaëlle Conseil; X Chris Le; Susan P C Cole; Elaine M Leslie
Journal:  Biochem Pharmacol       Date:  2016-09-19       Impact factor: 5.858

6.  Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4).

Authors:  Aina Westrheim Ravna; Georg Sager
Journal:  Bioorg Med Chem Lett       Date:  2008-05-16       Impact factor: 2.823

7.  Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.

Authors:  K Lee; M G Belinsky; D W Bell; J R Testa; G D Kruh
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

8.  The relation between the divergence of sequence and structure in proteins.

Authors:  C Chothia; A M Lesk
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

9.  Exploring the effect of nsSNPs in human YPEL3 gene in cellular senescence.

Authors:  Abhishek Singh; Mukesh Thakur; Sujeet Kumar Singh; Lalit Kumar Sharma; Kailash Chandra
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

Review 10.  Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment.

Authors:  Tengjiao Fan; Guohui Sun; Xiaodong Sun; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Cancers (Basel)       Date:  2019-03-06       Impact factor: 6.639

View more
  4 in total

1.  Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991.

Authors:  Edgardo Becerra; Laura Berumen; Valeria Soto-Ontiveros; Guadalupe García-Alcocer
Journal:  Medicina (Kaunas)       Date:  2022-05-24       Impact factor: 2.948

Review 2.  Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking.

Authors:  Wei Zou; Birui Shi; Ting Zeng; Yan Zhang; Baolin Huang; Bo Ouyang; Zheng Cai; Menghua Liu
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

3.  Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.

Authors:  Vigneshwaran Namasivayam; Katja Stefan; Jens Pahnke; Sven Marcel Stefan
Journal:  Comput Struct Biotechnol J       Date:  2021-11-27       Impact factor: 7.271

4.  Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics.

Authors:  Marco Tutone; Anna Maria Almerico
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.